Prevalence of Cognitive Impairment before Prostate Cancer Treatment

Prevalence of Cognitive Impairment before Prostate Cancer Treatment

Cognitive impairment is common among patients with different types of cancer, even before cancer treatment, but no data were reported among patients with prostate cancer (PCa), who may be at high risk due to advanced age. This study aims to estimate the prevalence of cognitive impairment before PCa...

Full description

Bibliographic Details
Main Authors: Natália Araújo, Adriana Costa, Catarina Lopes, Luisa Lopes-Conceição, Augusto Ferreira, Filipa Carneiro, Jorge Oliveira, Samantha Morais, Luís Pacheco-Figueiredo, Luis Ruano, Vítor Tedim Cruz, Susana Pereira, Nuno Lunet
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
prostate cancer
prevalence study
cognitive dysfunction/epidemiology
neuropsychological test
Online Access:https://www.mdpi.com/2072-6694/14/5/1355

Internet

https://www.mdpi.com/2072-6694/14/5/1355

Similar Items